Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Cone Dystrophy 3 × Panitumumab × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 4 Urinary Bladder Neoplasms 2 Kidney Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Rectal Neoplasms 1 Pancreatic Neoplasms 1 Lung Neoplasms 1 Esophageal Neoplasms 1 Cone Dystrophy 3 1 Colonic Neoplasms 1 Carcinoma, Renal Cell 1

Interventions

Panitumumab 1 Gemcitabine 1 Cystectomy 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01916109 2016-02-12

Study of Gemcitabine, Carboplatin, and Panitumumab (GCaP) as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer

Memorial Sloan Kettering Cancer Center

Phase 2 Terminated

4 enrolled 6 charts

Cone Dystrophy 3, Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡